Ms. Cunningham currently serves as Managing Partner of i3 Strategy Partners, a firm focused on helping pharma companies plan and execute successful portfolio strategies and commercial launches. Most recently Ann’s firm has been focused on partnering with pharmaceutical and biotech companies on clinical trial recruitment in communities of color as well as addressing health inequities.
Her experience in the pharmaceutical industry includes multiple instrumental roles: Chief Commercial Officer and Board Member at VistaGen Therapeutics; Vice President, Neurodegenerative Disease and Psychiatry at Teva Pharmaceuticals; Senior Director, Global Brand Lead, Rexulti, at Otsuka; and Senior Director, Global Brand Lead and Sales Director in multiple therapeutic areas at Eli Lilly and Company.
Ms. Cunningham holds a B.A. in Psychology from Yale University and an M.B.A. from University of Michigan, Stephen M. Ross School of Business.
Prior to working in the pharmaceutical industry Ann served as a licensed social worker and Director of Rehabilitative Services in an Ohio correctional facility.
Ann has two adult children, Sheila and Richard, and in her free time she enjoys golf, travel and fitness.